Akkaya, C. Et Al. 2006. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , vol.21, no.5 , 337-345.

Akkaya, C., Sivrioglu, E. Y., Akgoz, S., Eker, S. S., & Kirli, S., (2006). Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , vol.21, no.5, 337-345.

Akkaya, CENGİZ Et Al. "Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study," HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , vol.21, no.5, 337-345, 2006

Akkaya, CENGİZ Et Al. "Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study." HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , vol.21, no.5, pp.337-345, 2006

Akkaya, C. Et Al. (2006) . "Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study." HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , vol.21, no.5, pp.337-345.

@article{article, author={CENGİZ AKKAYA Et Al. }, title={Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: An open label study}, journal={HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL}, year=2006, pages={337-345} }